Mahindra & Mahindra Executes Novation Agreement for Life Insurance Joint Venture
Mahindra & Mahindra has executed a Novation and Amendment Agreement with Manulife, transferring all rights and obligations from Manulife to its wholly owned subsidiary Manulife Holdings (Bermuda) Limited for their life insurance joint venture. The transaction maintains all original JV terms while completing necessary regulatory compliance and exchange notifications.

*this image is generated using AI for illustrative purposes only.
Mahindra & Mahindra has executed a Novation and Amendment Agreement with Manulife and Manulife Holdings (Bermuda) Limited, marking an important development in their joint venture arrangement for the life insurance business. The agreement was executed under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Transaction Details
The novation agreement involves the complete transfer of rights, interests, and obligations from Manulife to its wholly owned subsidiary, Manulife Holdings (Bermuda) Limited. This transfer is in accordance with the original Joint Venture Agreement executed for the incorporation of a joint venture company to carry on life insurance business and activities incidental or ancillary thereto.
| Transaction Details: | Information |
|---|---|
| Reference Number: | M&M/SEC/2026-27/012 |
| Date of Execution: | 24 April 2026 at 12.44 p.m. |
| Parties Involved: | Mahindra & Mahindra, Manulife, Manulife Holdings (Bermuda) Limited |
| Transaction Type: | Novation and Amendment Agreement |
| Transfer Direction: | From Manulife to Manulife Bermuda |
| Business Purpose: | Life insurance and related activities |
Key Provisions
Pursuant to the agreement, Manulife has transferred, assigned, and novated all its rights, interests, and obligations under the Joint Venture Agreement to Manulife Bermuda. Manulife Bermuda has assumed all rights and obligations of Manulife under the JVA and shall be bound by the terms and conditions of the JVA. All other terms and conditions of the original Joint Venture Agreement remain unchanged.
Regulatory Compliance
The company has fulfilled all regulatory disclosure requirements under the transaction. The intimation regarding this development has been uploaded on the Company's website at mahindra.com and has been communicated to multiple stock exchanges.
| Exchange Communications: | Details |
|---|---|
| National Stock Exchange: | Scrip Symbol M&M |
| BSE Limited: | Scrip Code 500520 |
| International Exchanges: | Luxembourg Stock Exchange, London Stock Exchange Plc |
| ISIN Code: | USY541641194 |
| Company Secretary: | Sailesh Kumar Daga (FCS: 4164) |
The agreement represents a structural reorganization within the Manulife group while maintaining the fundamental terms of the life insurance joint venture partnership with Mahindra & Mahindra.
Historical Stock Returns for Mahindra & Mahindra
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.60% | -7.35% | -3.02% | -15.56% | +0.69% | +321.19% |
How might this corporate restructuring within Manulife impact the strategic direction and growth plans of the life insurance joint venture?
Will Manulife Holdings (Bermuda) Limited's involvement change the regulatory oversight or compliance requirements for the joint venture operations?
Could this transfer signal Manulife's broader strategy to consolidate its international insurance partnerships under its Bermuda subsidiary?

































